You are here: Industry Insights > Pfizer

News List

Merck/Pfizer up the pressure on BMS in first-line kidney cancer pharmaphorum
February 14, 2019
The FDA has started a speedy review of Merck KGaA and Pfizer’s new combination regimen for advanced kidney cancer, setting up a possible approval in June and piling more pressure on Bristol-Myers Squibb.
USFDA accepts Merck and Pfizer’s sBLA for Renal Cancer drug biospectrumasia
February 13, 2019
The clinical development program for avelumab, known as JAVELIN, involves at least 30 clinical programs and more than 9,000 patients evaluated across more than 15 different tumor types.
Pfizer recalls valsartan-containing blood pressure drug in Japan pharmaceutical-technology
February 13, 2019
Pfizer’s subsidiary in Japan has announced a recall of blood pressure drug Amvalo that was found to contain impurities in its active ingredient valsartan, which is indicated to treat high blood pressure....
FDA agrees to review Merck and Pfizer’s sBLA for Bavencio and Inlyta pharmaceutical-technology
February 13, 2019
The US Food and Drug Administration (FDA) has accepted a supplemental biologics license application (sBLA) submitted by Merck subsidiary EMD Serono and Pfizer for a Bavencio (avelumab) and Inlyta (axitinib) combination to .....
Pfizer and Lilly announce top-line results from second Phase 3 study of tanezumab in osteoarthritis pain worldpharmanews
January 30, 2019
Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced positive top-line results from a Phase 3 study evaluating tanezumab 2.5 mg or 5 mg in patients with moderate-to-severe osteoarthritis (OA) pain.
Cipla receives approval for Pfizer’s Depo-Provera biospectrumasia
January 29, 2019
It is a progestin indicated only for the prevention of pregnancy
Pfizer workers in Ireland fight to keep old school pensions fiercepharma
January 28, 2019
Most American companies have managed to ditch defined pension plans in the last two decades, but Pfizer is having difficulty convincing some holdouts at manufacturing plants in Ireland.
FamilyTech Wearables Company JOY Partners with Pfizer Latin America firstwordpharma
January 23, 2019
FamilyTech Company JOY is partnering with Pfizer Mexico to disseminate its first product, the Octopus Watch, to children in Mexico living with a chronic health condition known as growth hormone deficiency (GHD).
Why GlaxoSmithKline and Pfizer are spinning out their consumer health business firstwordpharma
January 21, 2019
GlaxoSmithKline and Pfizer are among the drugmakers that are seeking to offload non-core units in an effort to increase focus, Business Insider reported Friday.
FDA agrees to review Pfizer’s NDAs for tafamidis pharmaceutical-technology
January 16, 2019
The US Food and Drug Administration (FDA) has accepted Pfizer’s two new drug applications (NDAs) for tafamidis to treat transthyretin amyloid cardiomyopathy (ATTR-CM).....

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page